IN2014DN07797A - - Google Patents
Info
- Publication number
- IN2014DN07797A IN2014DN07797A IN7797DEN2014A IN2014DN07797A IN 2014DN07797 A IN2014DN07797 A IN 2014DN07797A IN 7797DEN2014 A IN7797DEN2014 A IN 7797DEN2014A IN 2014DN07797 A IN2014DN07797 A IN 2014DN07797A
- Authority
- IN
- India
- Prior art keywords
- disintegrating
- components
- tablet
- wet granulation
- component
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 abstract 5
- 239000003826 tablet Substances 0.000 abstract 4
- 238000005550 wet granulation Methods 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 3
- 239000001913 cellulose Substances 0.000 abstract 2
- 229920002678 cellulose Polymers 0.000 abstract 2
- 239000008187 granular material Substances 0.000 abstract 2
- 239000006191 orally-disintegrating tablet Substances 0.000 abstract 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000001768 carboxy methyl cellulose Substances 0.000 abstract 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 abstract 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 abstract 1
- 238000007906 compression Methods 0.000 abstract 1
- 230000006835 compression Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012075832 | 2012-03-29 | ||
| JP2012206896 | 2012-09-20 | ||
| JP2012206895 | 2012-09-20 | ||
| JP2012275942 | 2012-12-18 | ||
| PCT/JP2013/059083 WO2013146917A1 (ja) | 2012-03-29 | 2013-03-27 | 酸型カルボキシメチルセルロースを含む崩壊性粒子組成物の製造方法、並びに、該組成物及び該組成物を含む口腔内崩壊錠剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN07797A true IN2014DN07797A (OSRAM) | 2015-05-15 |
Family
ID=49260166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN7797DEN2014 IN2014DN07797A (OSRAM) | 2012-03-29 | 2013-03-27 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20150174075A2 (OSRAM) |
| EP (1) | EP2832350B1 (OSRAM) |
| JP (1) | JP5996633B2 (OSRAM) |
| KR (1) | KR101707938B1 (OSRAM) |
| CN (1) | CN104080443B (OSRAM) |
| IN (1) | IN2014DN07797A (OSRAM) |
| TW (1) | TWI610691B (OSRAM) |
| WO (1) | WO2013146917A1 (OSRAM) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN2014DN07797A (OSRAM) | 2012-03-29 | 2015-05-15 | Daicel Corp | |
| CN104010663B (zh) | 2012-09-20 | 2021-02-19 | 株式会社大赛璐 | 含酸式羧甲基纤维素和结晶纤维素的崩解性颗粒组合物及含该组合物的口腔内崩解片剂 |
| EP3020416A4 (en) * | 2013-07-06 | 2016-12-07 | Daicel Corp | ULTRASONICALLY DECOMPOSED TABLET AND METHOD FOR THE PRODUCTION THEREOF |
| US9974738B2 (en) | 2013-09-27 | 2018-05-22 | Daicel Corporation | Disintegrating particle composition produced by two-stage wet granulation process, and intraorally disintegrating tablet containing same composition |
| CN105555262A (zh) * | 2013-09-27 | 2016-05-04 | 株式会社大赛璐 | 含有崩解性颗粒组合物的口腔内崩解片剂 |
| JP2017036214A (ja) * | 2013-12-10 | 2017-02-16 | 株式会社ダイセル | 炭酸塩を含む口腔内崩壊錠剤用組成物及び口腔内崩壊錠剤 |
| WO2015163135A1 (ja) * | 2014-04-21 | 2015-10-29 | 株式会社ダイセル | 微小繊維状セルロースを含む崩壊性粒子組成物 |
| JP2017226600A (ja) * | 2014-10-16 | 2017-12-28 | 株式会社ダイセル | 超速崩壊錠剤 |
| WO2016084493A1 (ja) | 2014-11-24 | 2016-06-02 | 株式会社ダイセル | 粉砕乳糖又は造粒乳糖を含む崩壊性粒子組成物 |
| JPWO2016098459A1 (ja) * | 2014-12-17 | 2017-09-28 | 株式会社ダイセル | 遅延崩壊性粒子組成物 |
| WO2016103904A1 (ja) * | 2014-12-25 | 2016-06-30 | 株式会社ダイセル | 超速崩壊錠剤及びその製造方法 |
| JP5897196B1 (ja) * | 2015-10-05 | 2016-03-30 | 大同化成工業株式会社 | 糖又は糖アルコール、膨潤型結合剤、崩壊剤及び高吸収性賦形剤を含む複合化造粒物及びその製造方法 |
| WO2018021265A1 (ja) | 2016-07-27 | 2018-02-01 | 沢井製薬株式会社 | 口腔内崩壊錠添加用組成物 |
| TWI650142B (zh) | 2016-09-06 | 2019-02-11 | 日商澤井製藥股份有限公司 | 口腔内崩解錠添加用組成物 |
| US20210275459A1 (en) * | 2018-07-25 | 2021-09-09 | Daicel Corporation | Disintegrating particulate composition containing microfibrous cellulose but not containing excipient |
| JP7360460B2 (ja) * | 2019-06-07 | 2023-10-12 | あゆみ製薬株式会社 | 口腔内崩壊錠及びその製造方法 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2851453A (en) * | 1954-08-09 | 1958-09-09 | Smith Kline French Lab | Cellulose derivative product, compositions comprising the same and their preparation |
| JPH10182436A (ja) | 1996-10-31 | 1998-07-07 | Takeda Chem Ind Ltd | 固形医薬製剤 |
| JP2000273039A (ja) | 1999-01-20 | 2000-10-03 | Taisho Pharmaceut Co Ltd | 口腔内崩壊性組成物 |
| JP4284017B2 (ja) * | 2000-10-06 | 2009-06-24 | 武田薬品工業株式会社 | 固形製剤 |
| CA2424770A1 (en) * | 2000-10-06 | 2003-04-03 | Takeda Chemical Industries, Ltd. | Solid pharmaceutical preparation |
| JP4551627B2 (ja) | 2003-02-28 | 2010-09-29 | 東和薬品株式会社 | 口腔内崩壊錠剤の製造方法 |
| JP4505859B2 (ja) | 2003-08-08 | 2010-07-21 | 味の素株式会社 | ナテグリニド含有製剤 |
| US20080274178A1 (en) * | 2005-08-10 | 2008-11-06 | Shionogi & Co., Ltd. | Orally Disintegrating Tablet |
| JP5123517B2 (ja) | 2005-11-14 | 2013-01-23 | 帝人ファーマ株式会社 | アンブロキソール口腔内速崩性錠剤 |
| US8298576B2 (en) * | 2006-11-17 | 2012-10-30 | Supernus Pharmaceuticals, Inc. | Sustained-release formulations of topiramate |
| JP5766899B2 (ja) * | 2007-04-11 | 2015-08-19 | ニプロ株式会社 | 口腔内崩壊剤及びその製造方法 |
| JP2008285434A (ja) | 2007-05-16 | 2008-11-27 | Taisho Pharm Ind Ltd | 口腔内速崩壊錠 |
| JP5627455B2 (ja) | 2007-06-06 | 2014-11-19 | ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ | 速崩性錠剤製造のための医薬製剤 |
| WO2009102038A1 (ja) * | 2008-02-13 | 2009-08-20 | Dainippon Sumitomo Pharma Co., Ltd. | 口腔内崩壊錠 |
| CN102988318A (zh) * | 2008-11-25 | 2013-03-27 | 田边三菱制药株式会社 | 口腔速崩片及其制备方法 |
| JP4920798B2 (ja) | 2009-08-11 | 2012-04-18 | 大日本住友製薬株式会社 | ２種以上の粒子を含有する口腔内速崩壊錠 |
| JP5674666B2 (ja) | 2009-08-11 | 2015-02-25 | 富士化学工業株式会社 | 崩壊性粒子組成物及び口腔内速崩壊錠 |
| US9198861B2 (en) * | 2009-12-22 | 2015-12-01 | Mallinckrodt Llc | Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans |
| US20110150989A1 (en) | 2009-12-22 | 2011-06-23 | Mallinkckrodt Inc. | Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans |
| JP6073543B2 (ja) | 2010-07-08 | 2017-02-01 | 沢井製薬株式会社 | ロラタジン含有口腔内崩壊錠の製造方法 |
| JP5630902B2 (ja) * | 2010-08-26 | 2014-11-26 | 沢井製薬株式会社 | ゾルピデム酒石酸塩含有口腔内崩壊錠の製造方法 |
| JP6245677B2 (ja) | 2012-01-20 | 2017-12-13 | ニプロ株式会社 | 口腔内崩壊錠 |
| IN2014DN07797A (OSRAM) | 2012-03-29 | 2015-05-15 | Daicel Corp | |
| CN104010663B (zh) | 2012-09-20 | 2021-02-19 | 株式会社大赛璐 | 含酸式羧甲基纤维素和结晶纤维素的崩解性颗粒组合物及含该组合物的口腔内崩解片剂 |
| US9974738B2 (en) * | 2013-09-27 | 2018-05-22 | Daicel Corporation | Disintegrating particle composition produced by two-stage wet granulation process, and intraorally disintegrating tablet containing same composition |
| WO2016084493A1 (ja) * | 2014-11-24 | 2016-06-02 | 株式会社ダイセル | 粉砕乳糖又は造粒乳糖を含む崩壊性粒子組成物 |
| TWI690333B (zh) * | 2015-06-29 | 2020-04-11 | 日商大賽璐股份有限公司 | 易服用性固態製劑（有核錠）之製造方法及易服用性固態製劑 |
-
2013
- 2013-03-27 IN IN7797DEN2014 patent/IN2014DN07797A/en unknown
- 2013-03-27 KR KR1020147030257A patent/KR101707938B1/ko active Active
- 2013-03-27 EP EP13767870.2A patent/EP2832350B1/en active Active
- 2013-03-27 CN CN201380004422.XA patent/CN104080443B/zh active Active
- 2013-03-27 WO PCT/JP2013/059083 patent/WO2013146917A1/ja not_active Ceased
- 2013-03-27 JP JP2014507973A patent/JP5996633B2/ja active Active
- 2013-03-27 US US14/384,358 patent/US20150174075A2/en not_active Abandoned
- 2013-03-29 TW TW102111387A patent/TWI610691B/zh active
-
2019
- 2019-10-11 US US16/600,066 patent/US12059501B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| TWI610691B (zh) | 2018-01-11 |
| US12059501B2 (en) | 2024-08-13 |
| KR101707938B1 (ko) | 2017-02-17 |
| TW201400145A (zh) | 2014-01-01 |
| EP2832350B1 (en) | 2019-07-17 |
| EP2832350A1 (en) | 2015-02-04 |
| US20150045452A1 (en) | 2015-02-12 |
| CN104080443A (zh) | 2014-10-01 |
| US20150174075A2 (en) | 2015-06-25 |
| WO2013146917A1 (ja) | 2013-10-03 |
| JP5996633B2 (ja) | 2016-09-21 |
| US20200038332A1 (en) | 2020-02-06 |
| EP2832350A4 (en) | 2015-11-18 |
| KR20140144249A (ko) | 2014-12-18 |
| CN104080443B (zh) | 2017-12-12 |
| JPWO2013146917A1 (ja) | 2015-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN07797A (OSRAM) | ||
| WO2014014835A3 (en) | Criystalline forms of the prolyl hydroxylase inhibitor [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid | |
| WO2014101986A8 (en) | Dry granulation process for producing tablet compositions of metformin and compositions thereof | |
| WO2013152051A3 (en) | Improved production of fatty acid derivatives | |
| HK1206779A1 (en) | Modified polynucleotides for the production of nuclear proteins | |
| IN2013MN02445A (OSRAM) | ||
| BR112012011995A2 (pt) | uso de prostaglandinas f2alfa e análogos para a cicatrização de lesões da córnea e conjuntiva. | |
| IN2015DN02907A (OSRAM) | ||
| NZ628964A (en) | Supercritical hydrolysis of biomass | |
| BR112013026297A2 (pt) | ésteres de resina de colofônia para não tecidos | |
| BR112013022638A2 (pt) | processo para a produção de açúcares hemicelulósicos fermentáveis e biomassa com baixo teor de cinzas a partir de biomassa celulósica; processo para a produção de açúcares hemicelulósicos fermentáveis e potência a partir de biomassa celulósica; e processo para a produção de açúcares hemicelulósicos fermentáveis e péletes de biomassa a partir de biomassa celulósica | |
| NZ593787A (en) | Lyophilised dabigatran | |
| WO2014199322A3 (en) | Wear resistant compositions with low particulate contamination and method of making those compositions | |
| EA201201119A1 (ru) | Панель гипсокартона и способ изготовления панели гипсокартона | |
| PH12015500794A1 (en) | Monohydrate crystal of fimasartan potassium salt, method for preparing same, and pharmacological composition comprising same | |
| CA2876532C (en) | Process for producing cell culture media | |
| WO2014182684A3 (en) | Methods and compositions related to large scale production of proteins | |
| MX359554B (es) | Microesferas cristalinas y proceso para fabricacion de las mismas. | |
| TR201009167A2 (tr) | Sefalosporin içeren farmasötik granüller. | |
| IN2014DN09313A (OSRAM) | ||
| MX368061B (es) | Proceso de radioetiquetado. | |
| TR201103625A1 (tr) | Sefuroksim içeren tablet formülasyonu üretim prosesi. | |
| WO2013092887A3 (en) | High surface area composition comprised of lignin | |
| MX346497B (es) | Compuestos para la diferenciacion de celulas madre mejorada en hepatocitos. | |
| HK1210436A1 (en) | Novel cell compositions and methods |